Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
Clinical trial NCT03764553 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03764553
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2025-07-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.